Ovarian Cancer – Bradley Monk, MD, and Robert Figlin, MD, provide post ESMO ’19 clinical update

Ovarian Cancer – Bradley Monk, MD, and Robert Figlin, MD, provide post ESMO ’19 clinical update

Thursday October 10, 2019

Robert Figlin, MD, Steven Spielberg Family Chair in Hematology-Oncology, Cedars-Sinai Medical Center and Bradley Monk, MD, FACOG, FACS, Professor and Director of the Division of Gynecologic Oncology at Creighton University School of Medicine, discuss ovarian cancer clinical updates from ESMO 19

Featured Videos

Frederick Locke, MD, regarding the clinical evidence supporting CAR-T cell therapies in MM

Noa Biran, MD, explains how JNJ-4528 differs from other CAR-T products

Amrita Krishnan, MD, tells us about the results of the Phase 1 study investigating CC-93269 in MM